Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

von Minckwitz G, Schwedler K, Schmidt M. et al
GBG 26/BIG 03-05 study group and participating investigators. Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.

Eur J Cancer 2011;
47 (15) 2273-2281

Bibliographische Angaben herunterladen

Aufrufen in: